TY - JOUR AU - Jemal, A. AU - Siegel, R. AU - Xu, J. AU - Ward, E. PY - 2010 DA - 2010// TI - Cancer statistics. 2010 JO - CA Cancer J Clin VL - 60 UR - https://doi.org/10.3322/caac.20073 DO - 10.3322/caac.20073 ID - Jemal2010 ER - TY - STD TI - Mok TS, Wu YL, Thongprasert S, Yang CH, Chu DT, Saijo N, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med. 2009;361:947–57. ID - ref2 ER - TY - JOUR AU - Rosell, R. PY - 2012 DA - 2012// TI - Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicenter, open-label, randomized phase 3 trial JO - Lancet Oncol VL - 13 UR - https://doi.org/10.1016/S1470-2045(11)70393-X DO - 10.1016/S1470-2045(11)70393-X ID - Rosell2012 ER - TY - JOUR AU - Hishida, T. AU - Yoshida, J. AU - Aokage, K. AU - Nagai, K. AU - Tsuboi, M. PY - 2016 DA - 2016// TI - Long-term outcome of surgical resection for residual or regrown advanced non-small cell lung carcinomas following EGFR-TKI treatment: report of four cases JO - Gen Thorac Cardiovasc Surg VL - 7 UR - https://doi.org/10.1007/s11748-014-0508-5 DO - 10.1007/s11748-014-0508-5 ID - Hishida2016 ER - TY - JOUR AU - Takamochi, K. AU - Suzuki, K. AU - Sugimura, H. AU - Funai, K. AU - Mori, H. AU - Bashar, A. H. AU - Kazui, T. PY - 2007 DA - 2007// TI - Surgical resection after gefitinib treatment in patients with lung adenocarcinoma harboring epidermal growth factor receptor gene mutation JO - Lung Cancer VL - 58 UR - https://doi.org/10.1016/j.lungcan.2007.04.016 DO - 10.1016/j.lungcan.2007.04.016 ID - Takamochi2007 ER - TY - JOUR AU - Kappers, I. AU - Klomp, H. M. AU - Burgers, J. A. AU - Van Zandwijk, N. AU - Haas, R. L. AU - van Pel, R. PY - 2008 DA - 2008// TI - Neoadjuvant (induction) erlotinib response in stageIIIA non-small-cell lung cancer JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2008.16.3709 DO - 10.1200/JCO.2008.16.3709 ID - Kappers2008 ER - TY - JOUR AU - Levchenko, E. V. AU - Moiseyenko, V. M. AU - Matsko, D. E. AU - Iyevleva, A. G. AU - Ivantsov, A. O. AU - Yargnian, S. M. AU - Anisimov, V. V. AU - Semionov, I. I. AU - Imyanitor, E. N. PY - 2009 DA - 2009// TI - Down-staging of EGFR mutation-positive advanced lung carcinoma with gefitinib followed by surgical intervention: follow-up of two cases JO - Onkologie VL - 32 UR - https://doi.org/10.1159/000242220 DO - 10.1159/000242220 ID - Levchenko2009 ER - TY - JOUR AU - Hishida, T. AU - Nagai, K. AU - Mitsudomi, T. AU - Yokoi, K. AU - Kondo, H. AU - Horinouchi, H. AU - Akiyama, H. AU - Nagayasu, T. AU - Tsuboi, M. PY - 2010 DA - 2010// TI - Japan clinical oncology group. Salvage surgery for advanced non-small cell lung cancer after response to gefitinib JO - J Thorac Cardiovasc Surg VL - 140 UR - https://doi.org/10.1016/j.jtcvs.2010.06.035 DO - 10.1016/j.jtcvs.2010.06.035 ID - Hishida2010 ER - TY - JOUR AU - Shen, H. AU - Zhong, X. AU - Ge, X. Q. AU - Huang, J. J. AU - Yuan, Y. PY - 2010 DA - 2010// TI - Surgical resection of lung adenocarcinoma without EGFR mutation after neoadjuvant gefitinib treatment JO - Clin Respir J VL - 4 UR - https://doi.org/10.1111/j.1752-699X.2009.00167.x DO - 10.1111/j.1752-699X.2009.00167.x ID - Shen2010 ER - TY - JOUR AU - Liu, M. AU - Jiang, G. AU - He, W. AU - Zhang, P. AU - Song, N. PY - 2011 DA - 2011// TI - Surgical resection of locally advanced pulmonary adenocarcinoma after gefitinib therapy JO - Ann Thorac Surg VL - 92 UR - https://doi.org/10.1016/j.athoracsur.2011.02.021 DO - 10.1016/j.athoracsur.2011.02.021 ID - Liu2011 ER - TY - JOUR AU - Ong, M. AU - Kwan, K. AU - Kamel-Reid, S. AU - Vincent, M. PY - 2012 DA - 2012// TI - Neoadjuvant erlotinib and surgical resection of a stage iiia papillary adenocarcinoma of the lung with an L861Q activating EGFR mutation JO - Curr Oncol VL - 19 UR - https://doi.org/10.3747/co.19.908 DO - 10.3747/co.19.908 ID - Ong2012 ER - TY - JOUR AU - Hashimoto, K. AU - Horinouchi, H. AU - Ohtsuka, T. AU - Kohno, M. AU - Izumi, Y. AU - Hayashi, Y. AU - Nomori, H. PY - 2012 DA - 2012// TI - Salvage surgery for a super-responder by gefitinib therapy for advanced lung cancer JO - Gen Thorac Cardiovasc Surg VL - 60 UR - https://doi.org/10.1007/s11748-012-0087-2 DO - 10.1007/s11748-012-0087-2 ID - Hashimoto2012 ER - TY - JOUR AU - Marech, I. AU - Vacca, A. AU - Gnoni, A. AU - Silvestris, N. AU - Lorusso, V. PY - 2013 DA - 2013// TI - Surgical resection of locally advanced epidermal growth factor receptor (EGFR) mutated lung adenocarcinoma after gefitinib and review of the literature JO - Tumori VL - 99 ID - Marech2013 ER - TY - JOUR AU - Funakoshi, Y. AU - Takeuchi, Y. AU - Maeda, H. PY - 2013 DA - 2013// TI - Pneumonectomy after response to gefitinib treatment for lung adenocarcinoma JO - Asian Cardiovasc Thorac Ann VL - 21 UR - https://doi.org/10.1177/0218492312462834 DO - 10.1177/0218492312462834 ID - Funakoshi2013 ER - TY - JOUR AU - López-González, A. AU - Almagro, E. AU - Salas, C. AU - Varela, A. AU - Provencio, M. PY - 2013 DA - 2013// TI - Use of a tyrosine kinase inhibitor as neoadjuvant therapy for non-small cell lung cancer: a case report JO - Respir Med Case Rep VL - 9 ID - López-González2013 ER - TY - JOUR AU - Park, K. AU - Tan, E. H. AU - O’Byrne, K. AU - Zhang, L. AU - Boyer, M. AU - Mok, T. PY - 2016 DA - 2016// TI - Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-lung 7): a phase 2B, open-label, randomized controlled trial JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30033-X DO - 10.1016/S1470-2045(16)30033-X ID - Park2016 ER - TY - STD TI - Yu HA, Sima CS, Huang J, Solomon SB, Rimner A, Paik P, et al. Local therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors. J Thorac Oncol. 2013;8:346–51. ID - ref17 ER - TY - JOUR AU - Gomez, D. R. AU - Blumenschein, G. R. AU - Lee, J. J. AU - Hernandez, M. AU - Ye, R. AU - Camidge, D. R. AU - Doebele, R. C. AU - Skoulidis, F. AU - Gaspar, L. E. AU - Gibbons, D. L. PY - 2016 DA - 2016// TI - Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicenter, randomised, controlled, phase 2 study JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30532-0 DO - 10.1016/S1470-2045(16)30532-0 ID - Gomez2016 ER -